Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.54 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.50 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.50 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.46 |
| ▸ | ESR1 | P03372 | 2/20 | 0.44 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.44 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.43 |
| ▸ | ANPEP | P15144 | 1/20 | 0.43 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.43 |
| ▸ | DNPEP | Q9ULA0 | 1/20 | 0.43 |
| ▸ | MIF | P14174 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1537215 | 1.00 | SLC7A5 (0.54) | SLC7A5TAAR1SLC6A2FOLH1ESR1 | |
| Tyrosine SCHEMBL11338508 | 0.91 | SLC7A5 (0.60) | SLC7A5FOLH1ANPEPRNPEPDNPEP | |
| Tyrosine SCHEMBL2205390 | 0.89 | SLC7A5 (0.61) | SLC7A5TAAR1SLC6A2FOLH1ANPEP | |
| SCHEMBL4453960 | 0.89 | SLC7A5 (0.67) | SLC7A5TAAR1SLC6A2ESR1ESR2 | |
| SCHEMBL27680265 | 0.89 | SLC7A5 (0.67) | SLC7A5TAAR1SLC6A2ESR1ESR2 | |
| SCHEMBL11847587 | 0.88 | PPID (0.43) | SLC7A5ANPEPRNPEPDNPEP | |
| SCHEMBL2490445 | 0.88 | SLC7A5 (0.57) | SLC7A5TAAR1SLC6A2ESR1ESR2 | |
| SCHEMBL16443320 | 0.86 | SLC7A5 (0.56) | SLC7A5TAAR1SLC6A2ESR1ESR2 | |
| SCHEMBL16443319 | 0.86 | SLC7A5 (0.56) | SLC7A5TAAR1SLC6A2ESR1ESR2 | |
| SCHEMBL208390 | 0.86 | ANPEP (0.57) | SLC7A5TAAR1SLC6A2ANPEPRNPEP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110327248-A | A kind of composition and manufacture craft of no silicone oil conditioning hair | 广州优敏泉生物科技有限公司 | 2019-10-15 | — | — | CN | claimed |
| JP-4849764-B2 | — | — | 2012-01-11 | — | — | JP | claimed |
| WO-2002000687-A9 | ANTIMICROBIAL PEPTIDES AND METHODS OF USE THEREOF | UNIV BRITISH COLUMBIA (CA) | 2003-09-18 | — | — | WO | claimed |
| EP-1294745-A2 | ANTIMICROBIAL PEPTIDES AND METHODS OF USE THEREOF | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2003-03-26 | — | — | EP | claimed |
| US-6337317-B1 | AMINO ACID SEQUENCE PEPTIDES AS MICROBIOCIDES | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2002-01-08 | — | — | US | claimed |
| WO-2002000687-A2 | ANTIMICROBIAL PEPTIDES AND METHODS OF USE THEREOF | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2002-01-03 | — | — | WO | claimed |
| EP-0368920-A1 | LECTINES FIXING BETA-D-GALACTOSIDE. | IDEON CORP (US) | 1990-05-23 | — | — | EP | claimed |
| WO-1989000581-A1 | LECTINES FIXING BETA-D-GALACTOSIDE | IDEON CORPORATION (US) | 1989-01-26 | — | — | WO | claimed |
| EP-0210257-A4 | PROTEIN WHICH IS CHARACTERISTIC OF RHEUMATOID ARTHRITIS. | HURWITZ CHARLES (US) | 1988-01-20 | — | — | EP | claimed |
| EP-0210257-A1 | PROTEIN WHICH IS CHARACTERISTIC OF RHEUMATOID ARTHRITIS | HURWITZ, Charles (US) | 1987-02-04 | — | — | EP | claimed |
| WO-1986004588-A1 | PROTEIN WHICH IS CHARACTERISTIC OF RHEUMATOID ARTHRITIS | HURWITZ CHARLES (US) | 1986-08-14 | — | — | WO | claimed |
| US-12042530-B2 | Target peptides for immunotherapy and diagnostics | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2024-07-23 | — | — | US | disclosed |
| US-20230025608-A1 | TARGET PEPTIDES FOR IMMUNOTHERAPY AND DIAGNOSTICS | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2023-01-26 | — | — | US | disclosed |
| US-20220211828-A1 | TARGET PEPTIDES FOR OVARIAN CANCER THERAPY AND DIAGNOSTICS | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2022-07-07 | — | — | US | disclosed |
| US-20210154279-A1 | TARGET PEPTIDES FOR COLORECTAL CANCER THERAPY AND DIAGNOSTICS | UNIVERSITY OF VIRGINIA PATENT FOUNDATION | 2021-05-27 | — | — | US | disclosed |
| US-6040436-A | A CDNA; DIANGOSIS AND THERAPY OF CENTRAL NERVOUS SYSTEM DISORDERS, ANTIISCHEMIC AGENTS, THERAPY FOR LAMBERT-EATON SYNDROME | AMERICAN HOME PRODUCTS CORPORATION (US) | 2000-03-21 | — | — | US | disclosed |
| EP-0500589-A1 | PURIFIED PROTEIN AND BIOACTIVE PHARMACEUTICAL. | ALFACELL CORP (US) | 1992-09-02 | — | — | EP | disclosed |
| WO-1991007435-A1 | PURIFIED PROTEIN AND BIOACTIVE PHARMACEUTICAL | ALFACELL CORPORATION (US) | 1991-05-30 | — | — | WO | disclosed |
| EP-0368920-A1 | LECTINES FIXING BETA-D-GALACTOSIDE. | IDEON CORP (US) | 1990-05-23 | — | — | EP | disclosed |
| WO-1989000581-A1 | LECTINES FIXING BETA-D-GALACTOSIDE | IDEON CORPORATION (US) | 1989-01-26 | — | — | WO | disclosed |